Literature DB >> 11641162

Congenital pseudarthrosis of the tibia in pediatric patients: MR imaging.

A H Mahnken1, G Staatz, B Hermanns, R W Gunther, M Weber.   

Abstract

OBJECTIVE: The purpose of this study was to describe the characteristics of congenital pseudarthrosis of the tibia on MR images of infants and children and to assess the value of MR imaging in evaluating this disease.
CONCLUSION: MR imaging of congenital pseudarthrosis allows assessment of the type and extension of the disease. It is especially recommended for the evaluation of periosteal and soft-tissue changes near the pseudarthrosis.

Entities:  

Mesh:

Year:  2001        PMID: 11641162     DOI: 10.2214/ajr.177.5.1771025

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  4 in total

1.  Induced membrane technique for the treatment of congenital pseudarthrosis of the tibia: preliminary results of five cases.

Authors:  Stéphanie Pannier; Zagorka Pejin; Caroline Dana; Alain Charles Masquelet; Christophe Glorion
Journal:  J Child Orthop       Date:  2013-10-08       Impact factor: 1.548

2.  Congenital (infantile) pseudarthrosis of the fibula associated with osteofibrous dysplasia.

Authors:  Masanori Hisaoka; Hiroshi Hashimoto; Takayuki Ohguri; Takatoshi Aoki; Sumika Okamoto; Hidetoshi Tanaka; Nobukazu Okimoto; Toshitaka Nakamura; Tsuyoshi Ishida
Journal:  Skeletal Radiol       Date:  2004-07-16       Impact factor: 2.199

3.  Identification and characterization of NF1 and non-NF1 congenital pseudarthrosis of the tibia based on germline NF1 variants: genetic and clinical analysis of 75 patients.

Authors:  Guanghui Zhu; Yu Zheng; Yaoxi Liu; An Yan; Zhengmao Hu; Yongjia Yang; Shiting Xiang; Liping Li; Weijian Chen; Yu Peng; Nanbert Zhong; Haibo Mei
Journal:  Orphanet J Rare Dis       Date:  2019-09-18       Impact factor: 4.123

4.  Congenital pseudarthrosis of the tibia: Management and complications.

Authors:  Hitesh Shah; Marie Rousset; Federico Canavese
Journal:  Indian J Orthop       Date:  2012-11       Impact factor: 1.251

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.